Sinclair Pharma's Non-Surgical Facelift Gains Access To US Market Via Thermigen Deal
Executive Summary
Sinclair Pharma has gained access to the world’s largest aesthetics market by enlisting Thermigen as the exclusive US distributor of Silhouette InstaLift, a non-surgical alternative to facelifts.
You may also be interested in...
US Sales Of Sinclair Pharma's Silhouette InstaLift-Off
Aesthetics company Sinclair Pharma has reported headline growth of 51% in 2016 due to strong unexpected interest for its Silhouette Instalift product.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.